193 related articles for article (PubMed ID: 7870885)
21. Galanin microinjection into the dorsal periaqueductal gray matter produces paradigm-dependent anxiolytic effects.
Soares FR; Silote GP; Almeida-Santos AF; Aguiar DC; Schenberg LC; Beijamini V
Brain Res Bull; 2016 Mar; 121():42-7. PubMed ID: 26751815
[TBL] [Abstract][Full Text] [Related]
22. Benzodiazepine receptors in the periaqueductal grey mediate anti-aversive drug action.
Audi EA; Graeff FG
Eur J Pharmacol; 1984 Aug; 103(3-4):279-85. PubMed ID: 6092103
[TBL] [Abstract][Full Text] [Related]
23. The benzodiazepine midazolam acts on the expression of the defensive behavior, but not on the processing of aversive information, produced by exposure to the elevated plus maze and electrical stimulations applied to the inferior colliculus of rats.
Saito VM; Brandão ML
Neuropharmacology; 2015 Jan; 88():180-6. PubMed ID: 25107589
[TBL] [Abstract][Full Text] [Related]
24. GABAergic and glutamatergic modulation of exploratory behavior in the dorsomedial hypothalamus.
Jardim MC; Guimarães FS
Pharmacol Biochem Behav; 2001; 69(3-4):579-84. PubMed ID: 11509219
[TBL] [Abstract][Full Text] [Related]
25. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
Wada T; Fukuda N
Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
[TBL] [Abstract][Full Text] [Related]
26. Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray.
Viana MB; Graeff FG; Löschmann PA
Pharmacol Biochem Behav; 1997 Sep; 58(1):167-72. PubMed ID: 9264086
[TBL] [Abstract][Full Text] [Related]
27. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
28. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test.
Motta V; Penha K; Brandão ML
Psychopharmacology (Berl); 1995 Aug; 120(4):470-4. PubMed ID: 8539329
[TBL] [Abstract][Full Text] [Related]
29. Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter.
de-Oliveira RW; Guimarães FS
Braz J Med Biol Res; 1999 Dec; 32(12):1529-32. PubMed ID: 10585635
[TBL] [Abstract][Full Text] [Related]
30. Involvement of dorsolateral periaqueductal gray N-methyl-D-aspartic acid glutamate receptors in the regulation of risk assessment and inhibitory avoidance behaviors in the rat elevated T-maze.
Bertoglio LJ; Zangrossi H
Behav Pharmacol; 2006 Nov; 17(7):589-96. PubMed ID: 17021391
[TBL] [Abstract][Full Text] [Related]
31. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.
Martins AP; Marras RA; Guimarães FS
Depress Anxiety; 2000; 12(2):99-101. PubMed ID: 11091933
[TBL] [Abstract][Full Text] [Related]
32. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
De Araújo JE; Huston JP; Brandão ML
Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic effect of kynurenic acid microinjected into the dorsal periaqueductal gray matter of rats placed in the elevated plus-maze test.
Schmitt ML; Graeff FG; Carobrez AP
Braz J Med Biol Res; 1990; 23(8):677-9. PubMed ID: 2101093
[TBL] [Abstract][Full Text] [Related]
34. Microinjection of D-2-amino-7-phosphonoheptanoate into the dorsal periaqueductal gray matter reduces the pressor response to glutamate injected at the same site.
Batista-Da-Silva AP; Rae GA; Carobrez AP
Braz J Med Biol Res; 1990; 23(8):705-8. PubMed ID: 2101097
[TBL] [Abstract][Full Text] [Related]
35. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
De Souza MM; Schenberg LC; de Pádua Carobrez A
Behav Brain Res; 1998 Feb; 90(2):157-65. PubMed ID: 9521547
[TBL] [Abstract][Full Text] [Related]
36. Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist.
Da Cunha C; Wolfman C; Levi de Stein M; Ruschel AC; Izquierdo I; Medina JH
Funct Neurol; 1992; 7(5):401-5. PubMed ID: 1338052
[TBL] [Abstract][Full Text] [Related]
37. Maternal aggression in Wistar rats: effect of 5-HT2A/2C receptor agonist and antagonist microinjected into the dorsal periaqueductal gray matter and medial septum.
de Almeida RM; Giovenardi M; da Silva SP; de Oliveira VP; Stein DJ
Braz J Med Biol Res; 2005 Apr; 38(4):597-602. PubMed ID: 15962186
[TBL] [Abstract][Full Text] [Related]
38. Dorsal periaqueductal gray post-stimulation freezing is counteracted by neurokinin-1 receptor antagonism in the central nucleus of the amygdala in rats.
Carvalho MC; Santos JM; Brandão ML
Neurobiol Learn Mem; 2015 May; 121():52-8. PubMed ID: 25883049
[TBL] [Abstract][Full Text] [Related]
39. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test.
Aguiar MS; Brandão ML
Physiol Behav; 1996 Oct; 60(4):1183-6. PubMed ID: 8884951
[TBL] [Abstract][Full Text] [Related]
40. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey.
Martins AP; Marras RA; Guimarães FS
Neuroreport; 1997 Nov; 8(16):3601-4. PubMed ID: 9427334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
